Omnicell (OMCL) appoints Perry Genova as CTO

Go back to Omnicell (OMCL) appoints Perry Genova as CTO

Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer

March 24, 2025 4:01 PM UTC

Medical device, pharmaceutical, and life sciences expert tapped to lead Companys technology strategy and global engineering organization

FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq: OMCL) (Omnicell or the Company), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.

This press release features multimedia. View the full release here:... More